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Abstract
Background: The study seeks to understand the role of efflux pumps in multidrug resistance displayed by the clinical
isolates of Vibrio fluvialis, a pathogen known to cause cholera-like diarrhoea.
Methodology: Two putative MATE family efflux pumps (H- and D-type) were PCR amplified from clinical isolates of V.
fluvialis obtained from Kolkata, India, in 2006 and sequenced. Bioinformatic analysis of these proteins was done to predict
protein structures. Subsequently, the genes were cloned and expressed in a drug hypersusceptible Escherichia coli strain
KAM32 using the vector pBR322. The recombinant clones were tested for the functionality of the efflux pump proteins by
MIC determination and drug transport assays using fluorimeter.
Results: The sequences of the genes were found to be around 99% identical to their counterparts in V. cholerae. Protein
structure predicting servers TMHMM and I-TASSER depicted ten-twelve membrane helical structures for both type of
pumps. Real time PCR showed that these genes were expressed in the native V. fluvialis isolates. In the drug transport
assays, the V. fluvialis clinical isolates as well as recombinant E. coli harbouring the efflux pump genes showed the energy-
dependent and sodium ion-dependent drug transport activity. KAM32 cells harbouring the recombinant plasmids showed
elevated MIC to the fluoroquinolones, norfloxacin and ciprofloxacin but H-type pumps VCH and VFH from V. cholerae and V.
fluvialis respectively, showed decreased MIC to aminoglycosides like gentamicin, kanamycin and streptomycin. Decrease in
MIC was also observed for acriflavin, ethidium bromide, safranin and nalidixic acid.
Significance: Increased resistance towards fluoroquinolones exhibited due to these efflux pumps from multidrug resistant
clinical isolates of V. fluvialis implies that treatment procedure may become more elaborate for this simple but highly
infectious disease. To the best of our knowledge, this is the first report of cloning and characterization of efflux pumps from
multidrug resistant clinical isolates of V. fluvialis.
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Introduction
Vibrio fluvialis causes sporadic cases of diarrhoea clinically
indistinguishable from cholera. There have been reports of
increase in incidence of drug resistance in these organisms due
to the presence of various factors like integrons, plasmids, SXT
elements, mutations in topoisomerases and efflux pumps [1–4].
Some of the mechanisms by which microorganisms exhibit
resistance to antimicrobials are: drug inactivation or modification,
alteration of target site, alteration of metabolic pathway, reduced
drug accumulation and increased active efflux of the drugs across
the cell surface. Efflux pumps are one of the major determinants of
the accumulation of various compounds including antibacterials
inside a bacterial cell and are thought to work in synergy with
other mechanisms like target gene mutations and quinolone
resistance genes (qnr) to acquire clinical breakpoints for resistance
[5,6]. Efflux pumps were first recognized as a mode of drug
resistance in early 1980s against tetracycline [7]. These pumps
may be specific for one substrate or may transport a range of
structurally dissimilar compounds including antibiotics of multiple
classes. Efflux pumps are categorized into five major superfamilies
i.e the major facilitator superfamily (MFS), the ATP-binding
cassette family (ABC), the resistance-nodulation-division family
(RND), the small multidrug resistance protein family (SMR) and
multidrug and toxic compound extrusion family (MATE), the
latter being the newest member of antimicrobial transporters [8,9].
Classification of the efflux pumps is based on the sequence
homology and the source of energy they utilize for drug transport.
Efflux pumps usually consist of a monocomponent protein with
transmembrane spanning domains. However, in gram-negative
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transporters can be organized as tripartite systems in which the
efflux pump located in the inner membrane works in conjunction
with a periplasmic fusion protein and an outer membrane protein
[10]. NorM, a multidrug Na
+-antiporter, was the first MATE
family pump identified from V. parahaemolyticus [11]. It was found
to confer resistance to dyes, fluoroquinolones and aminoglycosides
[11]. NorM homologues have recently been characterized in many
species like Neisseria gonorrhoeae, Escherichia coli and V. cholerae [11–
14]. MATE family efflux pumps utilize Na
+/H
+ gradient for
transport and has been reported to contain three branches: the
NorM branch, a branch containing several eukaryotic proteins
and a branch containing E. coli DinF [15]. The X-ray structure of
NorM from V. cholerae has recently been solved to the resolution of
3.63 A ˚ [16].
Recent studies from our laboratory have suggested the role of
various mobile genetic elements as well as chromosome-borne
factors in multiple drug resistance of various clinical isolates of V.
fluvialis [3,17]. Though most of the studies of efflux pumps have
been done in V. cholerae O1 or non-O1/non-139 strains, studies
have not been envisaged in a lesser known organism like V. fluvialis.
In the present study, D- and H- MATE-type putative transporters
were cloned from clinical isolates of V. fluvialis and expressed in E.
coli to deduce their functionality and examine their contribution in
imparting drug resistance. Bioinformatic analysis was performed
to predict their 2D and 3D structures and correlate with the
findings from the functionality assays. Our results indicated that
these efflux pumps were functional when expressed in a
heterologous host and they displayed differential substrate
specificity.
Results
Gene cloning, sequencing, homology and structure
prediction
D- and H-MATE-type efflux pump genes were amplified from
genomic DNA of V.cholerae N16961 and two clinical isolates
L10734 and L12387 of V.fluvialis using published primers [18].
The sequences of recombinant clones from each of these three
strains were subsequently submitted to GenBank (EU140548–
EU140550, EU263360–EU263363). Amino acid sequence
alignments of VCD (from V. cholerae O1) and VFD (from V.
fluvialis) showed that they were more than 99% identical. Both
these pumps showed 97–98% homology with VcmD (D-type
MATE pump from non-O1/non-O139 strain of V.cholerae) [18].
Sequence analysis of VCH and VFH revealed that they were 99–
100% identical. Also, these were almost 99% similar to previously
cited VcmH efflux pump from V.cholerae non-O1/non-O139 [18].
In a BLAST search, all the four pumps showed 99% identity with
chromosome I of V.cholerae N16961 indicating that these efflux
pump genes could be chromosome-borne in V. cholerae as well as in
V. fluvialis. CLUSTAL W alignments of protein sequences of these
pumps with NorM from V. parahaemolyticus and YdhE and DinF
family proteins of E.coli suggested that VCH and VFH were closer
to NorM and YdhE branch (Figs. 1A and 1B). VCD and VFD
seemed to have evolved differently from NorM (Fig. 1B). Analysis
of nucleotide and amino acid sequences also revealed that the
sequences from V. fluvialis were closer to V. cholerae O1 as
compared to V. cholerae non-O1/non-O139.
Two-dimensional modeling for these pumps was done using
TMHMM server [19]. Significant differences were observed
between H- and D-type of pumps in terms of orientation of N-
and C-terminii, the number of transmembrane helices and the
loops in between the transmembrane helices (Figs. 2A and 2C).
The VFD/VCD pumps were predicted as having eleven
transmembrane helices with C-terminus located in the exterior
of the cell whereas VFH/VCH pumps showed ten transmembrane
helices and an internally disposed C-terminus (Figs. 2A and 2C). I-
TASSER server was used for 3D protein structure prediction [20].
Results revealed that the structures of two kinds of pumps were
actually different as observed in 2D predictions (Figs. 2B and 2D).
Additionally, the 3D structure for VFH was similar to the structure
predicted in X-ray crystallographic studies of NorM [16] whereas
the structure for VFD varied from that of NorM. This observation
also corroborated our earlier findings of CLUSTAL W analysis
where H- and D-pumps seemed to have evolved from different
branch points (Fig. 1).
Expression of efflux pump genes in the parent Vibrio
strain L12387
In order to confirm if the H- and D-pumps were actually
expressed in the parent Vibrio strains, real time PCR was
performed. Using atpA gene (encoding the a subunit of the F1
ATPase) as a control, mean cycle threshold (Ct) values, DCt and
fold change (2
DCt) were obtained for each gene. The results
showed that expression of the vfd gene was 12.1-fold higher as
compared to atpA gene and the expression of vfh gene was 1.1-fold
higher as compared to atpA. This proved that both the genes vfd
and vfh were expressed in the parent V. fluvialis strain though the
levels of expression varied between the two of them.
Change in MIC for E.coli host carrying recombinant
proteins
MIC assays were carried out to assess the functionality of the
four recombinant clones expressing VFH, VCH, VFD and VCD
in an E. coli host KAM32. A range of changes were observed in the
susceptibilities of E. coli cells producing either D- or H-type MATE
pumps (Table 1). Elevation in MIC was observed against some
compounds whereas decrease in MIC or unaltered MIC was
noticed in others. With fluoroquinolones like ciprofloxacin and
norfloxacin, two- to four-fold elevation in MIC was seen for both
types of pumps (Table 1). Most interesting observation was
decrease in MIC or increased susceptibility for nalidixic acid,
acriflavin, ethidium bromide, safranin and aminoglycosides like
gentamicin, kanamycin and streptomycin (Table 1). Unaltered
MIC was noticed in case of chloramphenicol, neomycin and
ofloxacin indicating that these drugs were not recognized by the
recombinant efflux pump proteins and therefore not transported
by them (Table 1). These results clearly proved that the
recombinant genes were expressed in a heterologous host and
were functional though the specificity of the transporters varied
with the compounds. It may be pertinent to state here that the
expression of these transporters appeared to be very low and
resulted in only modest changes (two- to four-folds) in bacterial
susceptibility to certain antimicrobials.
Presence of MATE-type efflux pumps in parent strains
To ascertain the presence of MATE efflux pumps in the parent
strains, ethidium bromide accumulation assays were carried out as
described in Materials and Methods. Both the parent strains
L10734 and L12387 were used for the assay yielding the same
results. Hence the data has been presented only for the strain
L12387. MATE pumps utilize energy from the proton motive
force (PMF) for transport of different substrates [12]. Altering the
generation of PMF using reserpine blocks pump activity resulting
in the enhanced accumulation of substrates [9,17]. Same effect
was observed when the V. fluvialis cells were treated with reserpine
Multidrug MATE Transporters from Vibrio fluvialis
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concentration inside the cells (Fig. 3A). When reserpine was
removed and glucose was added to energise the cells, the efflux
activity of the pumps in the parent strains was regained and the
active drug efflux was initiated that resulted in a drastic drop in the
intracellular concentration of the dye (Fig. 3A). Also, the efflux
activity was enhanced on addition of 100 mM NaCl (Fig. 3B).
Therefore, efflux of the dye was found to be energy-driven (Fig. 3A)
and Na
+-dependent (Fig. 3B).
Reduction of intracellular drug concentration in the
recombinant E. coli
The observed drug specificity of recombinant clones of VCD,
VFD, VCH and VFH for fluoroquinolones in MIC assays was
consistent with the drug recognition profiles of other members of
the MATE family [12,14,18]. To confirm the drug susceptibility
testing results, the levels of accumulation of norfloxacin were
measured in KAM32 cells that carried recombinant pBR322
encoding VCD, VFD, VCH and VFH. As shown for VCD, the
levels of norfloxacin accumulation increased radically in the
recombinant cells after the addition of reserpine (Fig. 4A). There
was a drop in the levels of norfloxacin accumulation on addition of
glucose (Fig. 4A). Interesting observation was made with ethidium
bromide accumulation in recombinant KAM32 cells compared to
the pBR322 control. MIC results had shown no change in MIC in
VCH and decrease in MIC in case of VFH, VCD and VFD which
was also reflected in the accumulation assay where VFH, VCD
and VFD exhibited more accumulation of the dye as compared to
VCH and control pBR322 (Fig. 4B).
D- and H-type efflux pumps are sodium-dependent
transporters
It has been shown in case of V. cholerae non-O1/non-O139 that
D- and H-type efflux pumps are Na
+/drug antiporters [18] but
there is paucity of information on their involvement in imparting
drug resistance in V. fluvialis. Thus, the levels of accumulation of
norfloxacin in KAM32 were investigated in the presence of Na
+ or
K
+ ions. The addition of 100 mM NaCl to KAM32 cells
harboring D- and H-type pump encoding genes resulted in a
greater efflux of the drug from these cells compared to the levels of
efflux observed in the presence of KCl or without salt (Fig. 5B).
This effect was not observed in the control pBR322/KAM32 cells
where same accumulation was observed in the presence of NaCl or
KCl (Fig. 5A). Taken together, the data suggest that these efflux
pump proteins are Na
+-dependent transporters. Furthermore, to
test the hypothesis that efflux of an antimicrobial by these proteins
Figure 1. Sequence analysis of MATE pumps from various organisms and expression of these genes in parent strains.A .Multiple
alignment of the amino acid sequences of VCD, VFD, VCH and VFH with those of representative homologs in Vibrio parahaemolyticus (NorM) and
Escherichia coli (DinF and YdhE) using CLUSTAL W2. *, identical residues. B. Phylogenetic analysis of the above mentioned proteins.
doi:10.1371/journal.pone.0035752.g001
Figure 2. 2D and 3D structure predictions of H- and D- type MATE pumps. A and C. Schematic representation of the predicted secondary
structure of VFD and VFH respectively. The topology was predicted based on the algorithm TMHMM Server 2.0. B and D. Schematic representation
of the predicted 3D structure of VFD and VFH respectively. The topology was predicted based on the algorithm I-TASSER.
doi:10.1371/journal.pone.0035752.g002
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+ -dependent, cells were first loaded with 100 mM norfloxacin
using reserpine as described in Materials and Methods. Thereaf-
ter, different concentrations of NaCl (50 to 200 mM) were added
to test their effects on drug efflux. The results showed that the
efflux activity increased with the increase in NaCl concentration
(Fig. 5C). Thus, drug accumulation and efflux assays confirmed




The present study was aimed at detailed characterization of the
efflux pump proteins from the not-so-well studied pathogen Vibrio
fluvialis responsible for sporadic cases of diarrhoea and also known
to be associated with pediatric diarrhoea [1–3]. Though a few
studies have been reported for the MATE pumps from V. cholerae
O1 and non-O1/non-O139 strains, no information is available on
the cloning and characterization of recombinant efflux pumps
from V. fluvialis to understand their role in multiple drug resistance
displayed by these organisms. To achieve this information, two
types of MATE pumps were isolated from multidrug resistant
clinical isolates of V. fluvialis with the objective of studying their
structure and function. Protein sequence analysis of VCD, VFD,
VCH and VFH along with other known homologs from V.
parahaemolyticus and E. coli suggested that VCH and VFH belonged
to common ancestral origin as that of NorM, a very well studied
MATE pump from various pathogens including Vibrios [11–16].
VFD and VCD seemed to have evolved differently. Asp32,
Glu251 and Asp367 from V.parahaemolyticus NorM have been
implicated in sodium-dependent transport of antimicrobials and
hence have a crucial role in imparting multidrug resistance [15].
Protein sequence alignment revealed that Asp32 was present in all
the four pumps. Glu251 of NorM was replaced by leucine in
VCD, VFD and DinF and by tryptophan in VCH and VFH.
Asp367 of NorM was replaced with alanine in VCD and VFD,
with glycine in DinF and with serine in VCH and VFH.
The crystal structure and previous predictions pertaining to its
secondary structure have suggested a twelve transmembrane
helical structure for NorM [14,16]. Models of the secondary
structure of VFD and VFH revealed that these were not 12-helical
structures like NorM. 3-Dimensional structure of VFD and VFH
corroborated the findings of phylogenetic analysis that predicted
structural similarity of VFH and structural diversity of VFD with
respect to NorM. This proved our hypothesis that D-and H-
MATE-type of efflux pumps have evolved differently. This was
also confirmed later in the functionality studies of these proteins as
assessed by MIC and drug transport assays.
Previous reports about NorM from V. parahaemolyticus have
depicted that it confers resistance to hydrophilic fluoroquinolones
such as norfloxacin and ciprofloxacin, but not to hydrophobic
quinolones such as sparfloxacin and nalidixic acid [11]. Though
NorM is the most well studied MATE pump in terms of its
structure and function, other MATE-type efflux pumps (VcmH,
VcmD, VcrM, VcmA, VcmB and VcmN) have also been
characterized from non-O1/non-O139 V.cholerae [18]. Our study
with H- and D-pumps from V. fluvialis also revealed that these
Table 1. Minimum inhibitory concentrations (MICs) for
recombinant clones carrying MATE-type efflux pump genes
from V. fluvialis and V. cholerae.
MIC in mg/mL for
Drug pBR322 VCH VFH VCD VFD
Acriflavin 25.0 12.5 6.25 12.5 12.5
Chloramphenicol 1.56 1.56 1.56 1.56 1.56
Ciprofloxacin 0.0045 0.009 0.009 0.009 0.009
Ethidium Bromide 12.5 12.5 6.25 6.25 6.25
Gentamicin 12.5 3.125 6.25 12.5 12.5
Kanamycin 25.0 12.5 12.5 25.0 25.0
Neomycin 25.0 25.0 25.0 25.0 25.0
Nalidixic Acid 3.125 0.78 1.56 0.78 1.56
Norfloxacin 0.019 0.078 0.039 0.039 0.039
Ofloxacin 0.039 0.039 0.039 0.039 0.039
Safranin 12.5 25.0 6.25 6.25 6.25
Streptomycin 12.5 6.25 6.25 12.5 12.5
VCH and VCD : pBR322 recombinant clones carrying H- and D- MATE pump
genes from V. cholerae N16961.
VFH and VFD : pBR322 recombinant clones carrying H- and D- MATE pump
genes from a clinical isolate of V. fluvialis.
doi:10.1371/journal.pone.0035752.t001
Figure 3. Presence of energy-dependent and Sodium-driven
transporters in parent strain of V. fluvialis.A .Level of intracellular
concentration of ethidium bromide in parent Vibrio fluvialis strain
L12387. Reserpine was added as membrane decoupler leading to
disruption in efflux activity and an increase in intracellular concentra-
tion of the dye. This effect was reversed on addition of glucose that
energized the cells and the efflux activity resulting in a sharp decline in
drug concentration inside the Vibrio cells. B. Decrease in the levels of
intracellular concentration of ethidium bromide in the parent strain in
the presence of 100 mM NaCl. Shown are the levels of accumulated dye
in the presence and the absence of the salt.
doi:10.1371/journal.pone.0035752.g003
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increased resistance towards norfloxacin and ciprofloxacin and
increased susceptibility towards nalidixic acid. Interestingly, only
VCH and VFH showed increased susceptibility towards amino-
glycosides suggesting increased intake of these compounds only by
H- and not D-type pumps. This kind of effect for increased
kanamycin permeability has also been observed earlier [15].
Decrease in MIC can be explained in terms of these drugs not
being recognised by the pumps as their substrates but being
permeabilised by some porin. As the bacterial cell is exposed to an
antibiotic, there are complex regulatory mechanisms that come
into play. These involve the MAR operon that regulates not only
efflux pumps, but also the porins. We hypothesise that the decrease
in MIC may be an outcome of such a mechanism where in
response to aminoglycosides, some porins get activated/overex-
pressed and allow the influx of these compounds thus increasing
the intracellular concentration of these drugs [21]. Previous studies
had revealed that Asp32 was responsible for norfloxacin resistance
as mutants of Asp32 showed low levels of norfloxacin resistance
[15]. As all these four pumps from V. fluvialis carried Asp at
position 32, they exhibited two- to four-fold rise in norfloxacin
resistance. These pumps exhibited increased susceptibility towards
dyes like ethidium bromide, acriflavin and safranin again
suggesting a channel-like function as noticed in the case of
aminoglycosides. Therefore, these interesting observations regard-
ing the different structures for two MATE pumps resulting in
differential substrate specificity need to be investigated further to
probe their channel-like function. In addition, it could be
interesting to look for efflux pump inhibitors to overcome the
drug resistance problem.
Materials and Methods
Bacterial strains and plasmids
Vibrio fluvialis isolates were obtained from patients with acute
cholera-like diarrhoea admitted to Infectious Diseases Hospital,
Kolkata, India, in 2006. All the isolates were kindly provided by
Dr. T. Ramamurthy, National Institute of Cholera and Enteric
Diseases, Kolkata, India, in the form of bacterial stabs. V. cholerae
O1 El Tor strain N16961 and V. fluvialis isolates L10734 (resistant
to neomycin, co-trimoxazole, nalidixic acid, trimethoprim and
partially resistant to ampicillin, kanamycin and ciprofloxacin) and
L12387 (resistant to neomycin, co-trimoxazole, nalidixic acid,
trimethoprim, ampicillin, streptomycin and sulfisoxazole and
partially resistant to kanamycin, chloramphenicol, norfloxacin
and ciprofloxacin) were used as the source of genomic DNA.
Escherichia coli JM109 was used for electroporation experiments and
E. coli strain KAM32 (DacrB, DydhE, hsd
2) was used for gene
expression [22]. Vector pDrive (QIAGEN GmbH, Hilden,
Germany) was used for TA cloning of PCR products and their
sequencing. Plasmid pBR322 was used for expression of the efflux
pump genes and functional characterization of the recombinant
proteins. V. cholerae and E. coli cells were grown in Luria-Bertani
medium at 37uC under aerobic condition. The study was
approved by the Institutional Biosafety Committee (IBSC) and
Review Committee on Genetic Manipulation (RCGM) governed
by guidelines laid down by the Department of Biotechnology,
Govt. of India.
DNA Preparation
Genomic and plasmid DNA were prepared from V.cholerae and
V.fluvialis cells as described earlier [23]. Plasmid Mini kit or Maxi
Kit (QIAGEN) were used for DNA purifications according to
manufacturer’s instructions. Gel extraction was done according to
manufacturer’s protocol (QIAGEN).
Polymerase chain reaction (PCR)
PCR assays were carried out using specific primers for D- and
H-type MATE pumps, and genomic DNA templates as described
earlier [18]. Each PCR involved an initial denaturation at 95uC
for 4 min, followed by 25 amplification cycles each consisting of an
initial denaturation at 95uC for 30 sec, annealing at 50uC for
1 min and extension at 72uC for 1 min 30 sec. Final polymeri-
sation was carried out at 72uC for 10 min. PCR reactions were
performed using PTC-225 DNA engine Tetrad
TM (MJ Research
Inc., Waltham, MA). Recombinant Taq polymerase (Fermentas
International Inc., Burlington, Ontario, Canada) was used along
Figure 4. Involvement of recombinant efflux pumps in the
transport of various compounds. A. VCD-induced efflux of
norfloxacin from recombinant E. coli harbouring vcd gene. pBR322:
Accumulation of norfloxacin in KAM32 cells transformed with pBR322
empty vector, VCD: Accumulation of norfloxacin in KAM32 cells
transformed with pBR322-vcd. *, the values of fluorescence for VCD
were significantly different for as compared to pBR322 control (P,0.05).
B. Accumulation of ethidium bromide in cells transformed with pBR322
empty vector (pBR), pBR322-vcd (VCD), pBR322-vfd (VFD), pBR322-vch
(VCH) and pBR322-vfh (VFH) *, the values of fluorescence for VFH were
significantly different as compared to pBR322 control (P,0.05). For
other recombinants it was significantly different at either of indicated
time points (P,0.05).
doi:10.1371/journal.pone.0035752.g004
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chloride was added at a final concentration of 2 mM.
Real Time PCR
RNA was isolated from the V. fluvialis isolate L12387 using
Trizol method. cDNA was generated using RevertAid H Minus
first strand cDNA synthesis kit (MBI, Fermentas). The cDNA was
amplified with TAQXpedite real time PCR master mix (Epicentre
Biotechnologies, Madison, WI), using the primers already
described [18]. atpA was used as a positive control.
Gene cloning
The PCR products of the right size (1573 bp for D amplicons
and 1531 for H amplicons) were purified from low melting point
agarose gel using the gel extraction kit (QIAGEN). The amplicons
were cloned in pDrive vector, electroporated in E. coli JM109 cells
and plated on LB containing ampicillin (100 mg/mL). The
recombinants were selected using blue/white screening and
restriction enzymes specific for each gene. Two positive clones
from each type of recombinant were sequenced. The sequenced
clones of D- and H-type efflux pump genes were designated vcd,
vfd, vch and vfh, where c stands for V. cholerae and f stands for V.
fluvialis. For construction of expression clones, DNA from the
recombinants described above were digested with BamHI and
approx. 1.4 kb insert was ligated into BamHI-digested pBR322
dephosphorylated with calf alkaline phosphatase (Fermentas). The
ligated product was electroporated in E.coli JM109 and plated on
LB plates containing ampicillin (50 mg/mL).
Drug susceptibility assays
The MICs of these recombinants were determined by two-fold
dilution method against various drug concentrations. The highest
concentration of each drug for the assay was prepared by addition
of 1000X concentrated stock of the drug to the appropriate
volume of LB medium containing ampicillin (50 mg/mL). Rest of
the concentrations for that drug were made by serial double
dilution method using LB medium containing ampicillin (50 mg/
mL). The recombinants were transformed in E. coli KAM32 cells
and plated on LB plates containing ampicillin (50 mg/mL). The
transformants were grown in LB medium containing ampicillin
(50 mg/mL) to an OD600 of 0.008–0.013. 2.0 mL of each drug
dilution was distributed in 24 well sterile tissue culture plates
(Corning, NY). 50 mL of bacterial culture was then added to each
drug concentration and the bacterial growth was monitored after
16–18 hours. The MICs were determined as the lowest concen-
tration of the drug that inhibited bacterial growth. The assays were
repeated atleast three times.
Ethidium Bromide accumulation assay in parent strains
Assays for ethidium bromide accumulation were performed as
described before with minor modifications [12]. V.cholerae N16961
and two V.fluvialis strains L10734 and L12387 were taken for this
study. Cells were grown in LB broth at 37uCt oa nO D 600 of 1.0,
harvested, washed thrice with buffer containing 0.1 M Tris.HCl,
pH 7.0, and suspended in the same buffer to an OD600 of 1.0. A
zero minute sample served as a negative control. Ethidium
Bromide was then added at a final concentration of 20 mg/mL.
Samples of 1 mL were collected at 5 min intervals throughout the
assay and these aliquots were stored in prechilled microcentrifuge
Figure 5. Sodium-ion dependence of recombinant efflux pumps Induction of norfloxacin efflux in the presence of 100 mM sodium chloride
(+NaCl) or 100 mM potassium chloride (+KCl) in the E. coli KAM32 cells transformed with A. pBR322 or B. pBR322-vfh. C. Effect of increase in Sodium
ion concentration on the efflux pump activity of VFH. *, The activity of VFH in the presence of 100 mM and 200 mM NaCl was significantly different
from that of the control without NaCl (P,0.05).
doi:10.1371/journal.pone.0035752.g005
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of 20 mg/mL to disrupt the proton gradient across the membrane.
Fifteen minutes later, reserpine was removed by centrifugation at
10,000 rpm for 4 min and the cells were resuspended in 0.1 M
Tris.HCl, pH 7.0 buffer containing 0.4% glucose and samples
were collected every 5 min. Samples of each time point were then
centrifuged at 10,000 rpm for 5 min at 4uC, washed once with 0.1
M Tris.HCl, pH 7.0 buffer and resuspended in 1 mL of 100 mM
glycine.HCl, pH 3.0. These samples were then shaken vigorously
for 2 h at 37uC to release the fluorescent content followed by
centrifugation at 15,000 rpm for 10 min at room temperature.
The fluorescence of the supernatants was measured at excitation
and emission wavelengths of 500 nm and 580 nm, respectively,
using a RF-5301 PC spectrofluorometer (Shimadzu, Singapore).
The amount of maximum fluorescence was normalized to 100%.
Drug accumulation assays with recombinant clones
For the assays with recombinants, E. coli KAM32 cells carrying
pBRVCD, pBRVFD, pBRVCH, pBRVFH or pBR322 were each
grown in LB medium containing ampicillin (50 mg/mL) to an
OD600 of 1.0 and processed exactly in the same way as described
above except that 100 mM norfloxacin was used instead of
ethidium bromide.
Accumulation of ethidium bromide in recombinant
clones
E. coli KAM32 cells containing pBRVCD, pBRVFD, pBRVCH,
pBRVFH or pBR322 were grown in LB broth at 37uCt oa nO D 600
of 1.0, harvested by centrifugation, washed thrice with buffer
containing 0.1M Tris.HCl, pH 7.0, and suspended in the same
buffer to an OD600 of 1.0. Ethidium bromide (final concentration
20 mg/ml) was added to the cell suspension and incubation was
carried out for 35–45 min to study the accumulation pattern.
Collection of the samples and measurement of the fluorescence
intensity was done exactly as described above.
Efflux of norfloxacin in the presence of Na
+
For the determination of norfloxacin efflux, recombinant
KAM32 cells were grown, harvested and washed as described
before. The cells were incubated in 0.1M Tris.HCl, pH 7.0 buffer
supplemented with 100 mM norfloxacin and 20 mg/mL reserpine
at 37uC for 30 min to load the cells with norfloxacin. The cells
were then pelleted, washed twice, and resuspended in the Tris
buffer to an OD600 of 2.0. After 15 min, the cell suspension was
divided into three equal portions; two portions received either
NaCl or KCl at final concentrations of 100 mM whereas the third
portion received equal volume of water. Samples of 1 ml were
taken at 3 mins intervals, centrifuged at 10,000 rpm for 5 mins at
4uC, and washed once with the same buffer. The fluorescence of
the supernatants were measured at an excitation and an emission
wavelengths of 277 nm and 448 nm, respectively.
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